InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Johnson Waynick Denelle, 管理人员. Officer active across 1 company, notably UCB. Cumulatively, 3 filings have been recorded. History available since 1 April 2026. The latest transaction was disclosed on 1 April 2026 (Purchase). Regulator: FSMA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Denelle Johnson Waynick is a senior executive at UCB, a biopharmaceutical company. She is responsible for managing operations and product innovation. Her expertise contributes to the growth and reputation of UCB in the market.